Narrow search
Showing 1 - 10 of 909
Cover Image
Mismeasurement in pay-for-performance : evidence from an intervention to reduce health care spending in China
Wu, Bingxiao - 2014
This paper examines how physicians in China respond to a pay-for-performance scheme that mismeasures performance. In 2005, China imposed a policy that penalizes hospitals with high drug sale percentage in the total revenue, with the intent to decrease drug expenditure. Using a unique...
Persistent link: https://www.econbiz.de/10010361468
Cover Image
Flexible drug approval policies
Bravo, Fernanda; Corcoran, Taylor C.; Long, Elisa F. - In: Manufacturing & service operations management : M & SOM 24 (2022) 1, pp. 542-560
Persistent link: https://www.econbiz.de/10012818779
Cover Image
"Let the sunshine in" : the impact of industry payment disclosure on physician prescription behavior
Guo, Tong; Sriram, S.; Manchanda, Puneet - In: Marketing science : the marketing journal of the … 39 (2020) 3, pp. 516-539
Persistent link: https://www.econbiz.de/10012294680
Cover Image
The effects of drug market regulation on pharmaceutical prices in Europe : overview and evidence from the market of ACE inhibitors
Schulenburg, Fritz von der; Vandoros, Sotiris; Kanavos, … - In: Health economics review 1 (2011) 18, pp. 1-8
in reducing pharmaceuticals prices. Results are not as strong for demand side measures. Profit controls and the use of …
Persistent link: https://www.econbiz.de/10009503923
Cover Image
The January effect: medication reinitiation among Medicare part D beneficiaries
Kaplan, Cameron; Zhang, Yuting - In: Health economics 23 (2014) 11, pp. 1287-1300
Persistent link: https://www.econbiz.de/10011308176
Cover Image
Free medicines thanks to retirement : impact of coinsurance exemption on pharmaceutical expenditures and hospitalization offsets in a national health service
Puig-Junoy, Jaume; García Gómez, Pilar; Casado Marin, … - In: Health economics 25 (2016) 6, pp. 750-767
Persistent link: https://www.econbiz.de/10011542205
Cover Image
Reference pricing and cost-sharing : theory and evidence on German off-patent drugs ; conference paper
Herr, Annika; Stühmeier, Torben; Wenzel, Tobias - 2014
-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference …
Persistent link: https://www.econbiz.de/10010489291
Cover Image
Are biopharmaceutical budget caps good public policy?
Goldman, Dana P.; Lakdawalla, Darius; Baumgardner, James R. - In: The Economists' voice 13 (2016) 1, pp. 27-42
Persistent link: https://www.econbiz.de/10011585711
Cover Image
Anticipatory behavior in response to Medicare Part D's coverage gap
Kaplan, Cameron M.; Zhang, Yuting - In: Health economics 26 (2017) 3, pp. 338-351
Persistent link: https://www.econbiz.de/10011815376
Cover Image
The economic driven by politics as values : the example of pharmaceuticals in France
Smith, Andy - In: New political economy 22 (2017) 6, pp. 611-627
Persistent link: https://www.econbiz.de/10011742973